Associations - NRAS (Neuroblastoma RAS viral oncogene homolog)

NRAS Q61	Colorectal Cancer	NRAS Q61	Colorectal Cancer	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1
NRAS Q61	Colorectal Cancer	NRAS Q61	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS G13	Colorectal Cancer	NRAS G13	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS G13	Colorectal Cancer	NRAS G13	Colorectal Cancer	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1
NRAS G12	Colorectal Cancer	NRAS G12	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS G12	Colorectal Cancer	NRAS G12	Colorectal Cancer	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1
NRAS A146	Colorectal Cancer	NRAS A146	Colorectal Cancer	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1
NRAS A146	Colorectal Cancer	NRAS A146	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS H117	Colorectal Cancer	NRAS H117	Colorectal Cancer	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1
NRAS H117	Colorectal Cancer	NRAS H117	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS A59	Colorectal Cancer	NRAS A59	Colorectal Cancer	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1
NRAS A59	Colorectal Cancer	NRAS A59	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS exon 4 mutation	Colorectal Cancer	NRAS exon 4 mutation	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS exon 3 mutation	Colorectal Cancer	NRAS exon 3 mutation	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS exon 2 mutation	Colorectal Cancer	NRAS exon 2 mutation	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS mutation	Colorectal Cancer	NRAS mutation	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS exon 4 mutation	Colorectal Cancer	NRAS exon 4 mutation	Colorectal Cancer	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1	cetuximab Resistant: A1 - Approval cetuximab Resistant : A1
RAS wild-type	Colorectal Cancer	RAS wild-type	Colorectal Cancer	regorafenib Sensitive: A1 - Approval regorafenib Sensitive : A1	regorafenib Sensitive: A1 - Approval regorafenib Sensitive : A1
RAS wild-type	Colorectal Cancer	RAS wild-type	Colorectal Cancer	panitumumab Sensitive: A1 - Approval panitumumab Sensitive : A1	panitumumab Sensitive: A1 - Approval panitumumab Sensitive : A1
NRAS mutation	Colorectal Cancer	NRAS mutation	Colorectal Cancer	cetuximab Resistant: A2 - Guideline cetuximab Resistant : A2	cetuximab Resistant: A2 - Guideline cetuximab Resistant : A2
NRAS mutation	Melanoma	NRAS mutation	Melanoma	binimetinib Sensitive: A2 - Guideline binimetinib Sensitive : A2	binimetinib Sensitive: A2 - Guideline binimetinib Sensitive : A2
NRAS exon 2 mutation	Colorectal Cancer	NRAS exon 2 mutation	Colorectal Cancer	cetuximab Resistant: A2 - Guideline cetuximab Resistant : A2	cetuximab Resistant: A2 - Guideline cetuximab Resistant : A2
NRAS exon 3 mutation	Colorectal Cancer	NRAS exon 3 mutation	Colorectal Cancer	cetuximab Resistant: A2 - Guideline cetuximab Resistant : A2	cetuximab Resistant: A2 - Guideline cetuximab Resistant : A2
NRAS mutation	Cutaneous Melanoma	NRAS mutation	Cutaneous Melanoma	binimetinib Sensitive: A2 - Guideline binimetinib Sensitive : A2	binimetinib Sensitive: A2 - Guideline binimetinib Sensitive : A2
NRAS mutation	Myelodysplastic Syndrome	NRAS mutation	Myelodysplastic Syndrome	ruxolitinib Sensitive: A2 - Guideline ruxolitinib Sensitive : A2	ruxolitinib Sensitive: A2 - Guideline ruxolitinib Sensitive : A2
RAS wild-type	Colorectal Cancer	RAS wild-type	Colorectal Cancer	cetuximab Sensitive: A2 - Guideline cetuximab Sensitive : A2	cetuximab Sensitive: A2 - Guideline cetuximab Sensitive : A2
NRAS wild-type	Rectal Cancer	NRAS wild-type	Rectal Cancer	panitumumab Sensitive: A2 - Guideline panitumumab Sensitive : A2	panitumumab Sensitive: A2 - Guideline panitumumab Sensitive : A2
NRAS wild-type	Colon Cancer	NRAS wild-type	Colon Cancer	panitumumab Sensitive: A2 - Guideline panitumumab Sensitive : A2	panitumumab Sensitive: A2 - Guideline panitumumab Sensitive : A2
NRAS wild-type	Colon Cancer	NRAS wild-type	Colon Cancer	cetuximab Sensitive: A2 - Guideline cetuximab Sensitive : A2	cetuximab Sensitive: A2 - Guideline cetuximab Sensitive : A2
NRAS wild-type	Rectal Cancer	NRAS wild-type	Rectal Cancer	cetuximab Sensitive: A2 - Guideline cetuximab Sensitive : A2	cetuximab Sensitive: A2 - Guideline cetuximab Sensitive : A2
NRAS mutation	Acute Myelogenous Leukemia	NRAS mutation	Acute Myelogenous Leukemia	gilteritinib Resistant: B - Late Trials gilteritinib Resistant : B	gilteritinib Resistant: B - Late Trials gilteritinib Resistant : B
RAS wild-type	Colorectal Cancer	RAS wild-type	Colorectal Cancer	fruquintinib Sensitive: B - Late Trials fruquintinib Sensitive : B	fruquintinib Sensitive: B - Late Trials fruquintinib Sensitive : B

NRAS (Neuroblastoma RAS viral oncogene homolog)

Associations(298)

Associations
(298)